发明名称
摘要 PURPOSE: An ELISA screening system for potential drugs that can improve obesity and type 2 diabetes is provided, thereby simply and rapidly screening the potential drugs that can improve obesity, type 2 diabetes. CONSTITUTION: A transformant Escherichia coli DH5@/PGEX4T-1-PPARγ2 (KCTC 10190BP) producing GST-PPARγ2(glutathione s-transferase-peroxisome proliferated activated receptor gamma isoform 2) is produced by transforming E. coli DH5@ with pGEX4T-1 containing human PPARγ2(peroxisome proliferated activated receptor gamma isoform 2) gene. A transformant E. coli BL21(DE3)/pET28a-SRC-1(633-708a.a) (KCTC 10191BP) producing SRC-1(steroid receptor co-activator01) is produced by transforming E. coli with pET28a containing SRC-1 gene. A screening method for potential drugs that can improve obesity and type 2 diabetes comprises analyzing the binding activity between the GAS-PPARγ2 protein and SRC-1 soluble fraction using ELISA.
申请公布号 KR100468046(B1) 申请公布日期 2005.01.24
申请号 KR20020021243 申请日期 2002.04.18
申请人 发明人
分类号 C12N1/21 主分类号 C12N1/21
代理机构 代理人
主权项
地址